Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

SOPHiA GENETICS (SOPH) Other Operating Expenses (2020 - 2025)

SOPHiA GENETICS's Other Operating Expenses history spans 6 years, with the latest figure at -$17000.0 for Q4 2025.

  • On a quarterly basis, Other Operating Expenses fell 114.66% to -$17000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$160000.0, a 200.63% decrease, with the full-year FY2025 number at -$86000.0, down 146.99% from a year prior.
  • Other Operating Expenses hit -$17000.0 in Q4 2025 for SOPHiA GENETICS, up from -$143000.0 in the prior quarter.
  • Over the last five years, Other Operating Expenses for SOPH hit a ceiling of $28.0 million in Q2 2021 and a floor of -$143000.0 in Q3 2025.
  • Historically, Other Operating Expenses has averaged $2.1 million across 5 years, with a median of $33500.0 in 2021.
  • Biggest five-year swings in Other Operating Expenses: crashed 2250.0% in 2022 and later skyrocketed 967.44% in 2023.
  • Tracing SOPH's Other Operating Expenses over 5 years: stood at $52000.0 in 2021, then soared by 384.62% to $252000.0 in 2022, then tumbled by 40.87% to $149000.0 in 2023, then dropped by 22.15% to $116000.0 in 2024, then tumbled by 114.66% to -$17000.0 in 2025.
  • Business Quant data shows Other Operating Expenses for SOPH at -$17000.0 in Q4 2025, -$143000.0 in Q3 2025, and $116000.0 in Q4 2024.